We report a case study of a 22-year-old woman with mitochondrial thymidine kinase 2 deficiency and chronic respiratory failure due to severe neuromuscular weakness requiring noninvasive positive pressure ventilation (NIPPV) since 12 years of age. During pregnancy and cesarean delivery, she was successfully supported with NIPPV. A multidisciplinary team approach should be used in pregnant patients with these disorders with specific attention to management of pulmonary complications, selection of route of delivery, anesthesia, and analgesia.
Introduction
Mitochondrial myopathies comprise a heterogenous group of neuromuscular diseases caused by dysfunction of the mitochondrial respiratory chain, and often result in respiratory insufficiency and depressed ventilatory drive. 1, 2 We report a case of a 22-year-old woman with mitochondrial disease secondary to thymidine kinase 2 deficiency and chronic respiratory failure who was successfully supported with noninvasive positive pressure ventilation (NIPPV) through pregnancy and cesarean delivery.
Case VS is a 22-year-old Hispanic woman with mitochondrial thymidine kinase 2 deficiency and chronic respiratory failure due to severe neuromuscular weakness requiring NIPPV. She has been followed at the Stanford University Pediatric Pulmonary Clinic for her chronic respiratory failure since 12 years of age.
Over a 10-year period, she had become progressively dependent on NIPPV for 22 h per day. In May 2006, pulmonary function testing revealed a forced vital capacity (FVC) of 1220 ml (32% predicted), and respiratory acidosis (pH of 7.27 and PC02 of 60) on venous blood gas (VBG) while off NIPPV. A chest radiograph, 12 lead electrocardiogram, and echocardiogram were normal. At that time her NIPPV settings were increased to an inspiratory positive airway pressure (IPAP) of 25 cm H 2 O, expiratory positive airway pressure (EPAP) of 6 cm H 2 O, and backup rate of 15 breaths on room air.
In October 2006, her pregnancy was identified during a pediatric pulmonology follow-up clinic appointment. Her pediatric pulmonologist referred her to the Stanford Maternal-Fetal Medicine Service. A multidisciplinary team was assembled to coordinate her care that included Maternal-Fetal Medicine, Pediatric and Adult Pulmonology, Obstetric Anesthesia, Genetics, Otolaryngology, Neonatology, nutrition and social work. During a multidisciplinary clinic visit, the risks and benefits of proceeding with the pregnancy were discussed and a pregnancy termination was advised due to the anticipated perinatal risks given the patient's pulmonary status. The patient elected to proceed with the pregnancy. She was followed monthly and nocturnal polysomnograms and VBGs were obtained at 31/2 and 6 months of pregnancy (Table 1) . These studies revealed moderate hypocapnea on NIPPV with increased ventilatory settings during pregnancy.
She developed worsening dyspnea and required NIPPV 24 h per day. Her FVC decreased to 850 ml (22% predicted), and she was hospitalized multiple times for preeclampsia. Betamethasone was given for fetal lung maturity in anticipation of an early delivery.
Near delivery, there were discussions for optimal ventilation (NIPPV, endotracheal intubation or tracheostomy), anesthesia and mode of delivery. An evaluation was carried out to determine her ability to oxygenate and ventilate on NIPPV while supine, upright and during valsalva maneuver for tolerability of being in an extended supine position.
Owing to worsening preeclampsia at 33 weeks' gestation, a decision was made to proceed with cesarian section (breech) using epidural anesthesia and NIPPV. A female infant was delivered with Apgars of 7 at 1 min and 9 at 5 min with a birth weight of 1349 g.
After initial intubation, the infant was extubated to room air by 12 h of life. The infant was discharged home on day 28 of life.
Discussion
Mitochondrial myopathies are divided into two major categories: disorders caused by defects of mitochondrial genome (mtDNA) and those due to defects of the nuclear genome. The prevalence of mtDNA-related disorders in northern Europe has been reported from 6 to 16 per 100 000 supporting the conclusion that mitochondrial diseases are among the most common metabolic disorders. 1 Since 1990, isolated case reports of pregnancy and pregnancyrelated complications of various types of mitochondrial myopathy have been reported. [2] [3] [4] [5] [6] [7] [8] Respiratory insufficiency and depressed ventilatory drive is a known complication of mitochondrial myopathy and NIPPV may be helpful. 2 Noninvasive ventilation (NIV) refers to the provision of mechanical ventilation without the need for an invasive artificial airway or tracheostomy tube. NIPPV using a face mask or nasal interface conducts gas from a positive-pressure ventilator into the mouth or nose, and has become the predominant means of administering NIV throughout the world. NIPPV has long been used to treat chronic respiratory failure caused by chest-wall deformities, progressive neuromuscular disorders or central hypoventilation. 9 Our review of the case literature found only one case of a patient with mitochondrial myopathy presenting with restrictive pulmonary physiology secondary to neuromuscular weakness during pregnancy. This case required NIPPV only at night and progressively for only up to 20 h during pregnancy. 4 In contrast, our subject normally required NIPPV 20-22 h out of 24 h before her pregnancy, and required 24 h NIPPV support during the majority of her pregnancy and delivery. Four weeks after delivery, VS was seen back in the Pediatric Pulmonary Clinic. Clinically she felt well, but admitted due to increased fatigue and decreased use of her NIPPV as she took on the role of a new mother (Table 1) . Not surprisingly, her follow-up VBG reflected a resultant increase in her respiratory acidosis.
VS had a successful pregnancy with NIPPV despite her respiratory compromise and preeclampsia. Close monitoring of this patient during her pregnancy with utilization of NIV revealed persistent mild tachypnea and respiratory alkalosis while on NIPPV support. We found that despite these clinical findings, the patient's health was not compromised and she had a successful delivery of her baby. Although there may be many complex and patientspecific issues involved in the care for patients with advanced mitochondrial myopathy, the option of NIPPV should be considered when addressing a pregnancy and delivery. Close monitoring with a mulitidiciplinary team approach of the patient is critical to minimize potential complications.
